Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
Int J Cardiol
; 397: 131611, 2024 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-38030041
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart Failure
/
Heart Injuries
Limits:
Humans
Language:
En
Journal:
Int J Cardiol
Year:
2024
Document type:
Article